Advanced Therapies USA 2025 x KACTUS

By Hannah Flaherty

November 6, 2025

Menu

What is Advanced Therapies USA?

Advanced Therapies USA 2025 is the leading U.S. congress dedicated to advancing cell and gene therapies from research to commercialization. The event brings together global experts from biotech, pharma, academia, and manufacturing to exchange insights, showcase innovation, and accelerate next-generation treatments.

Through eight focused content tracks, live case studies, and high-impact networking sessions, the conference offers a comprehensive view of the scientific, technical, and regulatory developments shaping the future of advanced medicines

Event Overview

Venue: Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107

Dates: November 18th to 19th, 2024

Conference & Exhibits Open Day 1: Tuesday, 18 November, 2024, 8:00 AM - 7:00 PM
Conference & Exhibits Open Day 2: Wednesday, 19 November, 2024, 8:00 AM - 4:30 PM

Booth #617

Event Schedule

The Advanced Therapies USA 2025 agenda features two days packed with inspiring keynotes, expert-led track sessions, and panel discussions on topics spanning cell therapy, gene therapy, gene editing, manufacturing, and commercialization. For full details, refer to the official Advanced Therapies USA 2025 agenda.

Day 1: November 18, 2024

Keynote 1 – State of the Industry | 8:59 AM – 10:34 AM
Morning Networking Break – Meet the Start-Ups | 10:35 AM – 11:05 AM
Track Sessions from 11:05 AM – 11:50 AM
- Track 1: Cell Therapy
- Track 2: Innovation Showcase / Start-Up Pitch
- Track 3: Evidence, Pricing & Access
- Track 4: Gene Modified Cell Therapy
- Track 5: Gene Therapy
- Track 6: Cell Therapy Manufacturing
- Track 7: Viral Vector Manufacturing
- Track 8: Supply Chain & Logistics
Midday Sessions & Panels | 12:10 PM – 1:35 PM
Afternoon Sessions & Panels | 1:35 PM – 5:10 PM
Networking Drinks Reception | 5:50 PM – 7:00 PM

Day 2: November 19, 2024

Morning Keynotes & Sessions | 8:00 AM – 10:30 AM
Morning Networking Break – Poster Presentation Session | 10:30 AM – 11:00 AM
Late-Morning Sessions & Panels | 11:00 AM – 12:30 PM
Lunch & Networking | 12:30 PM – 1:00 PM
Afternoon Sessions & Panels | 1:00 PM – 4:00 PM
Closing Remarks & Final Networking | 4:00 PM – 5:00 PM

Posters on Display

At Advanced Therapies USA 2025, KACTUS will showcase how our reagents and platforms support high-performance cell and gene therapy workflows—from edited T cells to AAV-based delivery.

We are presenting three posters:

High-Performing GMP CRISPR Cas9 Nuclease for Cell and Gene Therapy
The Second-Generation High-Fidelity Cytosine Base Editor AccuBase™ Can Proficiently Modify Multiple Genes Within a Human Primary T Cell While Minimizing Off-Target Effects
Tailored AAV Solutions: AAV ELISA Kits and Customized Variant Kit Development

Together, these posters demonstrate how KACTUS supports advanced therapy programs across gene editing, base editing, and AAV analytics, all underpinned by rigorous quality and reproducibility.

About KACTUS

KACTUS excels in crafting and producing an array of superior-grade, highly active recombinant proteins and enzymes, catering to diverse sectors like antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. Our expansive catalog, boasting over 3,000 recombinant proteins, encompasses a wide spectrum of targets, species, tags, and labels, each thoughtfully chosen to address the specific, unmet needs of scientists engaged in drug development. The hallmark of our product selection process is a rigorous emphasis on exceptional quality and a steadfast commitment to ensuring reliable supply, thereby upholding the highest standards of excellence and client satisfaction.